SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is surging following reports that the company is preparing a massive bid to acquire eBay, with retail investors buzzing over the potential for a transformative marketplace merger. While the community is actively debating the feasibility and financial structure of a deal of this scale, many traders are positioning themselves for potential volatility and short squeeze activity heading into the next session.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing significant upward momentum and heightened investor interest driven by a combination of strong institutional buying, a potential short squeeze setup, and anticipation ahead of the upcoming earnings report. The community is actively discussing the stock's high short interest and limited share availability, which many hope will trigger a sustained rally.

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in South Korea, Japan, and Turkey, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

eBay shares are experiencing significant volatility following a mixed quarterly report, where solid revenue beats are being overshadowed by a soft outlook and investor concerns regarding high seller fees. The community is actively debating the platform's long-term sustainability, focusing on the impact of AI-driven customer service transitions and the competitive pressure from other e-commerce marketplaces.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

Fannie Mae shares are surging following high-profile endorsements from Bill Ackman and Michael Burry, who labeled the stock "stupidly cheap" and highlighted its significant asymmetric upside potential. Investors are actively debating the timing of a potential privatization and uplisting, with community sentiment split between intense optimism over a long-awaited "halo trade" and skepticism regarding whether the recent price action is a pump-and-dump scheme.

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

The MELANIA crypto token continues to generate intense controversy within the community, with many investors labeling it a failed project following a significant loss in value since its launch. Discussion is dominated by heated debates over the Trump family's financial influence and skepticism regarding the utility or long-term legitimacy of politically-linked meme coins.

The Toronto-Dominion Bank engages in the provision of financial products and services. It operates through the following segments: Canadian Personal and Commercial Banking, U.S. Retail, Wealth Management and Insurance, Wholesale Banking, Corporate segment. The Canadian Personal and Commercial Banking segment is involved in the provision of deposit, saving, payment, and lending products and advice. It also offers customized products and services to help business owners meet financing, investment, cash management, international trade, and day-to-day banking needs through its network of commercial branches and specialized customer centers. The U.S. Retail segment focuses on personal, business banking, and wealth management operations in the U.S. The Wealth Management and Insurance segment offers wealth and asset management products and advice to retail clients in Canada through the direct investing, advice-based, and asset management businesses. The Wholesale Banking segment serves corporate, government, and institutional clients in key financial markets around the world. The Corporate segment consists of service and control groups, including technology solutions, shared services, treasury and balance sheet management, marketing, human resources, finance, risk management, compliance, anti-money laundering, legal, real estate, and others. The company was founded on February 1, 1955, and is headquartered in Toronto, Canada.

Toronto Dominion Bank

Toronto Dominion Bank is facing intense market volatility following a historic three-billion-dollar penalty for systemic anti-money laundering failures and a rare U.S. regulatory asset cap on its retail growth. While some investors are expressing deep concern over the bank's regulatory future and the potential impact on long-term expansion, others view the sharp sell-off as a compelling long-term entry point for a dividend-yielding blue-chip stock.

SkyAI is an all-in-one AI ecosystem powered by MCP, designed to seamlessly integrate intelligent solutions across industries.

SkyAI

SkyAI is experiencing significant volatility and aggressive trading volume, fueling intense community debate over whether it represents a sustainable momentum play or a short-term speculative pump. Traders are closely monitoring entry points and top-holder activity while comparing the coin's rapid price action to other high-momentum digital assets.

Advanced Biomed, Inc. operates as a holding company with interests in developing biochip technologies. It engages in the research & development of microfluidic biochip technologies and provides tumor diagnosis and treatment technology applications. The company was founded by Yi Lu and Steven I-Fang Cheng in 2014 and is headquartered in Tainan, Taiwan.

Advanced Biomed Inc

Advanced Biomed is attracting significant attention as traders target it for potential short-term momentum, citing its low-float profile and recent speculative buying volume. The community is actively debating the stock's parabolic potential, with many comparing it to other recent micro-cap runners while cautioning others about the inherent risks of volatility and pump-and-dump setups.

AXT, Inc. engages in the design, development, manufacture and distribution of compound and single element semiconductor substrates. It also sells specialty material substrates and raw materials used to make substrates and other related products. The company was founded by Morris S. Young and Davis Zhang in 1986 and is headquartered in Fremont, CA.

AXT Inc

AXT Inc. is seeing intense volatility driven by speculative momentum and institutional interest, with traders sharply divided between those betting on the company's critical role in AI photonics and those calling it a highly overvalued bubble. The conversation is dominated by fierce debate over the sustainability of its rapid price appreciation, concerns regarding potential share dilution, and intense skepticism from short-sellers who view the stock as a prime candidate for a significant correction.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is currently a major focus for traders due to heavy short interest and speculation regarding a potential leadership change or privatization, with community sentiment split between frustration over stagnant price action and conviction in a long-term turnaround. Investors are closely monitoring the board's lack of CEO progress while debating whether the brand's international expansion and current valuation present a deep value opportunity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Sees Large Increase in Short Interest

Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) saw a significant increase in short interest in April. As of April 15th, there was short interest totaling 411,325 shares, an increase of 477.3% from the March 31st total of 71,244 shares. Approximately 1.1% of the company's shares are...

Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Given Average Recommendation of "Buy" by Analysts

Shares of Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) have been given an average recommendation of "Buy" by the five brokerages that are currently covering the stock, MarketBeat...

Analysts Offer Predictions for Adagene FY2026 Earnings

Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Free Report) - Equities research analysts at HC Wainwright issued their FY2026 earnings estimates for Adagene in a research report issued on Tuesday, April 7th. HC Wainwright analyst A. He forecasts that the company will post earnings of ($0.37) per share fo...

Guggenheim Issues Positive Forecast for Adagene (NASDAQ:ADAG) Stock Price

Guggenheim raised their price target on Adagene from $9.00 to $10.00 and gave the stock a "buy" rating in a research report on Monday...

<ul class="summary-bullets"><li>Adagene also announced an update from the Phase 1b/2 study of Muzastotug in combination with Keytruda in patients with Microsatellite Stable Colorectal Cancer with no liver metastases.</li><li>The company stated that the results show an improved durability of response among patients in the trials.</li><li>Adagene added that Muzastotug, in combination with Merck’s Keytruda, has received Fast Track designation from the FDA.</li></ul>Adagene Inc. (ADAG) shares tanked nearly 10% in Thursday’s opening trade after the company announced a slew of updates, including the pricing of a $70 million public offering of its American depository shares.Adagene priced the public offering at $3.75 per ADS, representing a discount of nearly 19% from ADAG’s closing price on Wednesday. The offering is expected to close on April 6, 2026.Adagene also announced an update from the Phase 1b/2 study of Muzastotug in Combination with Keytruda in patients with Microsatellite Stable Colorectal Cancer (MSS CRC) with no liver metastases. The company stated that the results show an improved durability of response among patients in the trials.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/ADAG">Adagene</a> trended in the ‘bearish’ territory at the time of writing.<h2 class="st-heading-2">Adagene Provides Update On Muzastotug Trials</h2>The company stated that Muzastotug, in combination with Merck’s Keytruda, achieved an overall response rate (ORR) of 31% in the combined 20 mg/kg dose cohort, compared to an ORR of 13% in the 10 mg/kg dose cohort.Adagene added that the median duration of response (mDOR) has not yet been achieved in the 20 mg/kg dose cohort, with responses ongoing beyond 9 months. However, the 10 mg/kg dose cohort achieved an mDOR of 6.2 months.The Progression-Free Survival (PFS) stood at 6.7 months in the 20 mg/kg cohort, outlasting the 4.8 months observed in the 10 mg/kg dose cohort, according to the company.Adagene stated that Muzastotug, in combination with Merck’s Keytruda, has received Fast Track designation from the U.S. Food and Drug Administration (FDA).In the 10 mg/kg cohort, the median overall survival was 19.8 months, with 48% of patients alive at two years. In the 20 mg/kg cohort, one-year survival was 80.8%, compared with 70.1% in the 10 mg/kg cohort.The company added that there was a 4% discontinuation rate across the two doses, and that there were no dose-limiting toxicities observed.<h2 class="st-heading-2">Adagene Teams Up With Incyte</h2>Adagene stated that it has partnered with Incyte Corp. (INCY) to evaluate the combination of muzastotug and INCA33890 in patients with MSS CRC with or without liver metastases.The company added that as a monotherapy, INCA33890 has demonstrated promising clinical efficacy and safety in immune checkpoint sensitive and insensitive cancers, including MSS CRC with and without liver metastases.<a href="https://stocktwits.com/symbol/ADAG">ADAG stock</a> is up 130% year-to-date. The Invesco Golden Dragon China ETF (PGJ) is down 14% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tesla-china-made-ev-sales-march-2026/cZ7xoOYRI8R">Tesla’s China-Made EV Sales Rise 9% In March, Registering Fifth Straight Month Of Gains: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Trading digital board showing the data on global stock market crash. | Image source: Getty Images

Why Is ADAG Stock Tanking Today?

Adagene priced the public offering of its American depository shares at $3.75 per ADS, representing a discount of nearly 19% from ADAG’s closing price on Wednesday.

Equity

Adagene (NASDAQ:ADAG) Announces Earnings Results, Beats Expectations By $0.24 EPS

Adagene (NASDAQ:ADAG - Get Free Report) announced its earnings results on Wednesday. The company reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.28...

Short Interest in Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Expands By 44.6%

Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) was the recipient of a large growth in short interest during the month of March. As of March 13th, there was short interest totaling 74,016...

Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Given Consensus Recommendation of "Buy" by Analysts

Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) has been assigned a consensus rating of "Buy" from the five analysts that are currently covering the company, Marketbeat reports. One...

Adagene (NASDAQ:ADAG) Raised to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Adagene to a "hold" rating in a research report on Saturday...

Adagene (ADAG) to Release Earnings on Monday

Adagene (NASDAQ:ADAG) will be releasing its Q4 2025 earnings before the market opens on Monday, March 23. (View Earnings Report at...

Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.

ADAG
Adagene Inc - ADR

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest ADAG News

ADAGAdagene Inc - ADR